Print This Page

Click to View All Speakers

Gary Schummer





Workshop #97):  Neurofeedback Treatment of Dyslexia 

The prevalence of dyslexia ranges from 5-17% of school-aged children, with 40% of the entire population reading below grade level. Recent qEEG findings have led clinicians and researchers to treat dyslexia with Neurofeedback. Results have varied from minor improvements in comprehension to advancing three grade levels after 25 sessions. Neurofeedback promises to become a significant tool to remediate this pervasive disorder. This workshop will assist the participant to understand the complexity of the disorder, summarize training strategies derived thus far, and propose areas for future exploration.


Plenary #203):  Success Builds Sucess: Beyond the Double Blind 

Neurofeedback has many roads to success, depending on the definition of success. A model of success beyond that offered through research will be presented. We're speaking of the creation of many well managed effective treatment centers.

 

Details:

 

Workshop #97):  Neurofeedback Treatment of Dyslexia

The prevalence of dyslexia ranges from 5-17% of school-aged children, with 40% of the entire population reading below grade level (Shaywitz and Shaywitz, 1990). Recent findings derived from QEEG measures have led clinicians and researchers to treat dyslexia with Neurofeedback. Results at our center as well as those presented by other providers have varied from minor improvements in comprehension to advancing three grade levels after 25 sessions. If these pilot studies continue to domonstrate similar efficacy in future research, Neurofeedback will become a significant tool to remediate this pervasive disorder. This workshop will assist the participant to understand the complexity of the disorder, summarize training strategies derived thus far, and propose areas for future exploration.

 

Plenary #203):  Success Builds Sucess: Beyond the Double Blind

For Neurotherapy to be accepted into the mainstream, the scientific establishment has held out the threshold of the double blind study. Many within our field continue to work to overcome this threshold of acceptability. Others, like myself, believe successful double blind studies are but one way toward universal acceptance. Additionally things will likely not change significantly after several double blind studies are completed. If we examine parallel models we find that other treatment approaches that were once outside mainstream medicine gained acceptance due simply to overwhelming grass roots support and thoughtful clinic establishment. So to, the field of Neurofeedback has much to gain from this method coupled with research.

 

Contact Info:

Gary Schummer
24050 Madison St., #111
Torrance, California  90505

phone:

Click to View All Speakers